Expression of concern
Specific inhibition of tumor cells by oncogenic EGFR specific silencing by RNA interference
Paper Information
Record ID:
64868
Author(s):
Publication Date:
August 08, 2013
Retraction Date:
December 13, 2024
(<1 year years ago)
Subjects:
Specific Fields:
Biology - Cancer Biology - Cellular Biology - Molecular Genetics Medicine - Oncology
Biology - Cancer Biology - Cellular Biology - Molecular Genetics Medicine - Oncology
Institutions:
Country:
🇯🇵 JapanArticle Type:
Publisher:
PLoS
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Expression of concern Details
Retraction Reasons:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1371/journal.pone.0316041Citations (12)
12
Total Citations1
Post-Retraction(8.3%)
10
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
0
Within 30 days
1
Within 1 year
0
After 2+ years
109
Days since retraction (latest)
Retraction: Specific inhibition of tumor cells by oncogenic EGFR specific silencing by RNA interference
Unknown Authors
PLoS ONE
Open Access
Published: Apr 2025
109 days after retraction
Expression of Concern: Specific Inhibition of Tumor Cells by Oncogenic EGFR Specific Silencing by RNA interference
Unknown Authors
PLoS ONE
Open Access
Published: Dec 2024
1 citation
1 citation
Same day as retraction
Paper citing Specific inhibition of tumor cells by oncogenic EG...
Unknown Authors
Unknown Journal
Published: Oct 2024
73 days before retraction
Anti-TGF-β1 aptamer enhances therapeutic effect of tyrosine kinase inhibitor, gefitinib, on non-small cell lung cancer in xenograft model
Masaki Takahashi, Yoshifumi Hashimoto, Yoshikazu Nakamura
Molecular Therapy — Nucleic Acids
Open Access
Published: Jun 2022
10 citations
10 citations
898 days before retraction
Role of epigenetics in carcinogenesis: Recent advancements in anticancer therapy
Showket Hussain, Sonam Tulsyan, Sajad Ahmad Dar et al. (8 authors)
Seminars in Cancer Biology
Published: Jun 2021
32 citations
32 citations
1266 days before retraction
NF-κB activation is an early event of changes in gene regulation for acquiring drug resistance in human adenocarcinoma PC-9 cells
Masashi Fukuoka, Katsuji Yoshioka, Hirohiko Hohjoh
PLoS ONE
Open Access
Published: Aug 2018
20 citations
20 citations
2324 days before retraction
Current Transport Systems and Clinical Applications for Small Interfering RNA (siRNA) Drugs
Fang Liu, Chunfang Wang, Yuantao Gao et al. (10 authors)
Molecular Diagnosis & Therapy
Published: Jun 2018
36 citations
36 citations
2368 days before retraction
Neighbors' death is required for surviving human adenocarcinoma PC-9 cells in an early stage of gefitinib treatment
Masaki Takahashi, Masashi Fukuoka, Katsuji Yoshioka et al. (4 authors)
Biochemical and Biophysical Research Communications
Published: Sep 2016
3 citations
3 citations
3006 days before retraction
Delivery strategies and potential targets for siRNA in major cancer types
Sang Jin Lee, Min Ju Kim, Ick Chan Kwon et al. (4 authors)
Advanced Drug Delivery Reviews
Open Access
Published: May 2016
131 citations
131 citations
3118 days before retraction
Therapy for Dominant Inherited Diseases by Allele-Specific RNA Interference: Successes and Pitfalls
Delphine Trochet, Bernard Prudhon, Stéphane Vassilopoulos et al. (4 authors)
Current Gene Therapy
Open Access
Published: Aug 2015
26 citations
26 citations
3398 days before retraction
Non-coding RNAs in lung cancer
Biagio Ricciuti, Carmen Mecca, Lucio Crinò et al. (6 authors)
Oncoscience
Open Access
Published: Nov 2014
36 citations
36 citations
3681 days before retraction
Paper citing Specific inhibition of tumor cells by oncogenic EG...
Unknown Authors
Unknown Journal
Published: Dec 2013
4029 days before retraction
Related Records
This article has multiple records in the database due to different notices:
Record #64867
Apr 01, 2025Quick Stats
Total Citations:
12
Years Since Retraction:
<1 year
Open Access:
Yes
Last Checked:
Jul 24, 2025